{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:28:43Z","timestamp":1793374123482,"version":"4.5.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s40123-024-00942-x","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T02:02:23Z","timestamp":1713319343000},"page":"1427-1451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Oculomics: A Crusade Against the Four Horsemen of Chronic Disease"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5122-3568","authenticated-orcid":false,"given":"Emily J.","family":"Patterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5067-8691","authenticated-orcid":false,"given":"Alistair D.","family":"Bounds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4915-4353","authenticated-orcid":false,"given":"Siegfried K.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kadri-Langford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5743-3964","authenticated-orcid":false,"given":"Dan","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"942_CR1","volume-title":"Outlive: the science & art of longevity","author":"P Attia","year":"2023","unstructured":"Attia P, Gifford B. Outlive: the science & art of longevity. 1st ed. New York: Harmony; 2023.","edition":"1"},{"key":"942_CR2","first-page":"e153","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145:e153-639.","journal-title":"Circulation"},{"key":"942_CR3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year\u00a02020: an overview. Int J Cancer. 2021;149:778\u201389.","journal-title":"Int J Cancer"},{"key":"942_CR4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1474-4422(19)30029-8","volume":"18","author":"WM Carroll","year":"2019","unstructured":"Carroll WM. The global burden of neurological disorders. Lancet Neurol. 2019;18:418\u20139.","journal-title":"Lancet Neurol"},{"key":"942_CR5","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2174\/1871530323666230309144825","volume":"23","author":"K Madan","year":"2023","unstructured":"Madan K, Paliwal S, Sharma S, Kesar S, Chauhan N, Madan M. Metabolic syndrome: the constellation of co-morbidities, a global threat. Endocr Metab Immune Disord Drug Targets. 2023;23:1491\u2013504.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"#cr-split#-942_CR6.1","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Healthcare access and quality index 1990-2019. Institute for Health Metrics and Evaluation (IHME)"},{"key":"#cr-split#-942_CR6.2","unstructured":"2022. https:\/\/ghdx.healthdata.org\/record\/ihme-data\/gbd-2019-healthcare-access-and-quality-1990-2019. Accessed 2023 Dec 20."},{"key":"942_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413\u201346.","journal-title":"Lancet"},{"key":"942_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","volume":"364","author":"J Peto","year":"2004","unstructured":"Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004;364:249\u201356.","journal-title":"Lancet"},{"key":"942_CR9","unstructured":"National Health Service England. NHS urges women to book a cervical screening as a third don\u2019t take up vital offer. https:\/\/www.england.nhs.uk\/2023\/01\/nhs-urges-women-to-book-a-cervical-screening-as-a-third-dont-take-up-vital-offer\/. Accessed 2023 Dec 20."},{"key":"942_CR10","volume-title":"Development of the ocular lens","year":"2004","unstructured":"Lovicu FJ, Robinson ML, editors. Development of the ocular lens. Cambridge, UK: Cambridge University Press; 2004."},{"key":"942_CR11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.visres.2017.05.009","volume":"139","author":"M D\u00edaz-Cor\u00e1nguez","year":"2017","unstructured":"D\u00edaz-Cor\u00e1nguez M, Ramos C, Antonetti DA. The inner blood\u2013retinal barrier: cellular basis and development. Vision Res. 2017;139:123\u201337.","journal-title":"Vision Res"},{"key":"942_CR12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1098\/rspb.1987.0053","volume":"231","author":"J Howard","year":"1987","unstructured":"Howard J, Blakeslee B, Laughlin SB. The intracellular pupil mechanism and photoreceptor signal: noise ratios in the fly Lucilia cuprina. Proc R Soc Lond B Biol Sci. 1987;231:415\u201335.","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"942_CR13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archopht.1960.00950020717015","volume":"63","author":"DVN Reddy","year":"1960","unstructured":"Reddy DVN, Kinsey VE. Composition of the vitreous humor in relation to that of plasma and aqueous humors. Arch Ophthalmol. 1960;63:715\u201320.","journal-title":"Arch Ophthalmol"},{"key":"942_CR14","first-page":"252","volume":"13","author":"RC Augusteyn","year":"2007","unstructured":"Augusteyn RC. Growth of the human eye lens. Mol Vis. 2007;13:252\u20137.","journal-title":"Mol Vis"},{"key":"942_CR15","unstructured":"Bright R. Tabular view of the morbid appearances in 100 cases connected with albuminous urine. Guy\u2019 Hospital reports; 1836"},{"key":"942_CR16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.9.2.6","volume":"9","author":"SK Wagner","year":"2020","unstructured":"Wagner SK, Fu DJ, Faes L, et al. Insights into systemic disease through retinal imaging-based oculomics. Transl Vis Sci Technol. 2020;9:6.","journal-title":"Transl Vis Sci Technol"},{"key":"942_CR17","volume-title":"Global health estimates 2016: disease burden by cause, age, sex, by country and by region, 2000\u20132016","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Global health estimates 2016: disease burden by cause, age, sex, by country and by region, 2000\u20132016. Geneva, Switzerland: WHO; 2018."},{"key":"942_CR18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13167-023-00315-7","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang Y, Li C, Shi D, et al. Integrating oculomics with genomics reveals imaging biomarkers for preventive and personalized prediction of arterial aneurysms. EPMA J. 2023;14:73\u201386.","journal-title":"EPMA J"},{"key":"942_CR19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/07853890.2022.2034932","volume":"54","author":"X Huang","year":"2022","unstructured":"Huang X, Wang Z, Shen Z, et al. Projection of global burden and risk factors for aortic aneurysm\u2014timely warning for greater emphasis on managing blood pressure. Ann Med. 2022;54:553\u201364.","journal-title":"Ann Med"},{"key":"942_CR20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40942-023-00488-3","volume":"9","author":"AR Clausen","year":"2023","unstructured":"Clausen AR, Stokholm L, Blaabjerg M, Frederiksen KH, Pedersen FN, Grauslund J. Retinal artery occlusion does not act as an independent marker of upcoming dementia: results from a Danish 20-year cohort study. Int J Retina Vitreous. 2023;9:50.","journal-title":"Int J Retina Vitreous"},{"key":"942_CR21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/jcm12010152","volume":"12","author":"J-H Wu","year":"2022","unstructured":"Wu J-H, Liu TYA. Application of deep learning to retinal-image-based oculomics for evaluation of systemic health: a review. J Clin Med. 2022;12:152.","journal-title":"J Clin Med"},{"key":"942_CR22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s40123-022-00641-5","volume":"12","author":"L Arnould","year":"2023","unstructured":"Arnould L, Meriaudeau F, Guenancia C, et al. Using artificial intelligence to analyse the retinal vascular network: the future of cardiovascular risk assessment based on oculomics? A narrative review. Ophthalmol Ther. 2023;12:657\u201374.","journal-title":"Ophthalmol Ther"},{"key":"942_CR23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/diagnostics13010068","volume":"13","author":"RG Barriada","year":"2022","unstructured":"Barriada RG, Masip D. An overview of deep-learning-based methods for cardiovascular risk assessment with retinal images. Diagnostics. 2022;13:68.","journal-title":"Diagnostics"},{"key":"942_CR24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/tjo.TJO-D-23-00018","volume":"13","author":"Y Chan","year":"2023","unstructured":"Chan Y, Cheng C-Y, Sabanayagam C. Eyes as the windows into cardiovascular disease in the era of big data. Taiwan J Ophthalmol. 2023;13:151.","journal-title":"Taiwan J Ophthalmol"},{"key":"942_CR25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCULATIONAHA.121.057709","volume":"145","author":"SM Zekavat","year":"2022","unstructured":"Zekavat SM, Raghu VK, Trinder M, et al. Deep learning of the retina enables phenome- and genome-wide analyses of the microvasculature. Circulation. 2022;145:134\u201350.","journal-title":"Circulation"},{"key":"942_CR26","doi-asserted-by":"crossref","first-page":"afac065","DOI":"10.1093\/ageing\/afac065","volume":"51","author":"S Nusinovici","year":"2022","unstructured":"Nusinovici S, Rim TH, Yu M, et al. Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk. Age Ageing. 2022;51:afac065.","journal-title":"Age Ageing"},{"key":"942_CR27","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3390\/diagnostics12071714","volume":"12","author":"NC Khan","year":"2022","unstructured":"Khan NC, Perera C, Dow ER, et al. Predicting systemic health features from retinal fundus images using transfer-learning-based artificial intelligence models. Diagnostics. 2022;12:1714.","journal-title":"Diagnostics"},{"key":"942_CR28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41551-018-0195-0","volume":"2","author":"R Poplin","year":"2018","unstructured":"Poplin R, Varadarajan AV, Blumer K, et al. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Nat Biomed Eng. 2018;2:158\u201364.","journal-title":"Nat Biomed Eng"},{"key":"942_CR29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s42256-021-00427-7","volume":"4","author":"A Diaz-Pinto","year":"2022","unstructured":"Diaz-Pinto A, Ravikumar N, Attar R, et al. Predicting myocardial infarction through retinal scans and minimal personal information. Nat Mach Intell. 2022;4:55\u201361.","journal-title":"Nat Mach Intell"},{"key":"942_CR30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12916-022-02620-w","volume":"20","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Hu W, Chen R, et al. Retinal age gap as a predictive biomarker of stroke risk. BMC Med. 2022;20:466.","journal-title":"BMC Med"},{"key":"942_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajo.2020.03.027","volume":"217","author":"J Chang","year":"2020","unstructured":"Chang J, Ko A, Park SM, et al. Association of cardiovascular mortality and deep learning-funduscopic atherosclerosis score derived from retinal fundus images. Am J Ophthalmol. 2020;217:121\u201330.","journal-title":"Am J Ophthalmol"},{"key":"942_CR32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/tvst.9.2.28","volume":"9","author":"J Son","year":"2020","unstructured":"Son J, Shin JY, Chun EJ, Jung K-H, Park KH, Park SJ. Predicting high coronary artery calcium score from retinal fundus images with deep learning algorithms. Transl Vis Sci Technol. 2020;9:28.","journal-title":"Transl Vis Sci Technol"},{"key":"942_CR33","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1016\/S2589-7500(20)30216-8","volume":"2","author":"TH Rim","year":"2020","unstructured":"Rim TH, Lee G, Kim Y, et al. Prediction of systemic biomarkers from retinal photographs: development and validation of deep-learning algorithms. Lancet Digit Health. 2020;2:e526\u201336.","journal-title":"Lancet Digit Health"},{"key":"942_CR34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41551-020-00626-4","volume":"5","author":"CY Cheung","year":"2020","unstructured":"Cheung CY, Xu D, Cheng C-Y, et al. A deep-learning system for the assessment of cardiovascular disease risk via the measurement of retinal-vessel calibre. Nat Biomed Eng. 2020;5:498\u2013508.","journal-title":"Nat Biomed Eng"},{"key":"942_CR35","volume":"15","author":"L Zhang","year":"2020","unstructured":"Zhang L, Yuan M, An Z, et al. Prediction of hypertension, hyperglycemia and dyslipidemia from retinal fundus photographs via deep learning: a cross-sectional study of chronic diseases in central China. PLoS One. 2020;15:e0233166.","journal-title":"PLoS One"},{"key":"942_CR36","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(01)06253-5","volume":"358","author":"TY Wong","year":"2001","unstructured":"Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet. 2001;358:1134\u201340.","journal-title":"Lancet"},{"key":"942_CR37","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/aje\/kwp306","volume":"170","author":"K McGeechan","year":"2009","unstructured":"McGeechan K, Liew G, Macaskill P, et al. Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol. 2009;170:1323\u201332.","journal-title":"Am J Epidemiol"},{"key":"942_CR38","volume":"9","author":"D Shi","year":"2022","unstructured":"Shi D, Lin Z, Wang W, et al. A deep learning system for fully automated retinal vessel measurement in high throughput image analysis. Front Cardiovasc Med. 2022;9: 823436.","journal-title":"Front Cardiovasc Med"},{"key":"942_CR39","unstructured":"Yu F, Zhao J, Gong Y, et al. Annotation-free cardiac vessel segmentation via knowledge transfer from retinal images. arXiv. 2019. https:\/\/arxiv.org\/abs\/1907.11483. Accessed 2023 Dec 20."},{"key":"942_CR40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3991\/ijoe.v17i14.24819","volume":"17","author":"ME Hoque","year":"2021","unstructured":"Hoque ME, Kipli K. Deep learning in retinal image segmentation and feature extraction: a review. Int J Online Biomed Eng. 2021;17:103\u201318.","journal-title":"Int J Online Biomed Eng"},{"key":"942_CR41","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/HYPERTENSIONAHA.111.189142","volume":"60","author":"CY Cheung","year":"2012","unstructured":"Cheung CY, Ikram MK, Sabanayagam C, Wong TY. Retinal microvasculature as a model to study the manifestations of hypertension. Hypertension. 2012;60:1094\u2013103.","journal-title":"Hypertension"},{"issue":"9","key":"942_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1101\/2021.04.15.21255176","volume":"127","author":"Y Ma","year":"2021","unstructured":"Ma Y, Xiong J, Zhu Y, et al. Development and validation of a deep learning algorithm using fundus photographs to predict 10-year risk of ischemic cardiovascular diseases among Chinese population. Cardiovasc Med. 2021;127(9):85. https:\/\/doi.org\/10.1101\/2021.04.15.21255176.","journal-title":"Cardiovasc Med"},{"key":"942_CR43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40942-015-0005-8","volume":"1","author":"TE De Carlo","year":"2015","unstructured":"De Carlo TE, Romano A, Waheed NK, Duker JS. A review of optical coherence tomography angiography (OCTA). Int J Retina Vitr. 2015;1:5.","journal-title":"Int J Retina Vitr"},{"key":"942_CR44","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1167\/iovs.18-24090","volume":"59","author":"L Arnould","year":"2018","unstructured":"Arnould L, Guenancia C, Azemar A, et al. The EYE-MI pilot study: a prospective acute coronary syndrome cohort evaluated with retinal optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2018;59:4299.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"942_CR45","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/HJH.0000000000001916","volume":"37","author":"J Chua","year":"2019","unstructured":"Chua J, Chin CWL, Hong J, et al. Impact of hypertension on retinal capillary microvasculature using optical coherence tomographic angiography. J Hypertens. 2019;37:572\u201380.","journal-title":"J Hypertens"},{"key":"942_CR46","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1364\/BOE.10.001532","volume":"10","author":"J Wang","year":"2019","unstructured":"Wang J, Jiang J, Zhang Y, Qian YW, Zhang JF, Wang ZL. Retinal and choroidal vascular changes in coronary heart disease: an optical coherence tomography angiography study. Biomed Opt Express. 2019;10:1532\u201344.","journal-title":"Biomed Opt Express"},{"key":"942_CR47","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1364\/JOSAA.14.002884","volume":"14","author":"J Liang","year":"1997","unstructured":"Liang J, Williams DR, Miller DT. Supernormal vision and high-resolution retinal imaging through adaptive optics. J Opt Soc Am A Opt Image Sci Vis. 1997;14:2884.","journal-title":"J Opt Soc Am A Opt Image Sci Vis"},{"key":"942_CR48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.survophthal.2021.05.012","volume":"67","author":"E Bakker","year":"2022","unstructured":"Bakker E, Dikland FA, Van Bakel R, et al. Adaptive optics ophthalmoscopy: a systematic review of vascular biomarkers. Surv Ophthalmol. 2022;67:369\u201387.","journal-title":"Surv Ophthalmol"},{"key":"942_CR49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13167-016-0065-3","volume":"7","author":"S Hagan","year":"2016","unstructured":"Hagan S, Martin E, Enr\u00edquez-de-Salamanca A. Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine. EPMA J. 2016;7:15.","journal-title":"EPMA J"},{"key":"942_CR50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1442-9071.2001.00408.x","volume":"29","author":"V Evans","year":"2001","unstructured":"Evans V, Vockler C, Friedlander M, Walsh B, Willcox MD. Lacryglobin in human tears, a potential marker for cancer. Clin Exp Ophthalmol. 2001;29:161\u20133.","journal-title":"Clin Exp Ophthalmol"},{"key":"942_CR51","first-page":"177","volume":"6","author":"A Lebrecht","year":"2009","unstructured":"Lebrecht A, Boehm D, Schmidt M, Koelbl H, Schwirz RL, Grus FH. Diagnosis of breast cancer by tear proteomic pattern. Cancer Genomics Proteomics. 2009;6:177\u201382.","journal-title":"Cancer Genomics Proteomics"},{"key":"942_CR52","first-page":"75","volume":"6","author":"A Lebrecht","year":"2009","unstructured":"Lebrecht A, Boehm D, Schmidt M, Koelbl H, Grus FH. Surface-enhanced laser desorption\/ionisation time-of-flight mass spectrometry to detect breast cancer markers in tears and serum. Cancer Genomics Proteomics. 2009;6:75\u201383.","journal-title":"Cancer Genomics Proteomics"},{"key":"942_CR53","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3892\/or.2012.1849","volume":"28","author":"D B\u00f6hm","year":"2012","unstructured":"B\u00f6hm D, Keller K, Pieter J, et al. Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach. Oncol Rep. 2012;28:429\u201338.","journal-title":"Oncol Rep"},{"key":"942_CR54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13195-020-00677-4","volume":"12","author":"ML Subramanian","year":"2020","unstructured":"Subramanian ML, Vig V, Chung J, et al. Neurofilament light chain in the vitreous humor of the eye. Alzheimers Res Ther. 2020;12:111.","journal-title":"Alzheimers Res Ther"},{"key":"942_CR55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.euroneuro.2023.02.016","volume":"70","author":"C Demirlek","year":"2023","unstructured":"Demirlek C, Atas F, Yalincetin B, et al. Choroidal structural analysis in ultra-high risk and first-episode psychosis. Eur Neuropsychopharmacol. 2023;70:72\u201380.","journal-title":"Eur Neuropsychopharmacol"},{"key":"942_CR56","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamapsychiatry.2023.0171","volume":"80","author":"SK Wagner","year":"2023","unstructured":"Wagner SK, Cortina-Borja M, Silverstein SM, et al. Association between retinal features from multimodal imaging and schizophrenia. JAMA Psychiat. 2023;80:478\u201387.","journal-title":"JAMA Psychiat"},{"issue":"4","key":"942_CR57","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/schbul\/sbu070","volume":"40","author":"P Kochunov","year":"2014","unstructured":"Kochunov P, Elliot Hong L. Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage. Schizophr Bull. 2014;40(4):721\u2013728. https:\/\/doi.org\/10.1093\/schbul\/sbu070","journal-title":"Schizophr. Bull."},{"key":"942_CR58","doi-asserted-by":"publisher","first-page":"797072","DOI":"10.3389\/fcell.2021.797072","volume":"9","author":"C Li","year":"2021","unstructured":"Li C, Yang T, Ou R, Shang H. Overlapping genetic architecture between schizophrenia and neurodegenerative disorders. Front Cell Dev Biol. 2021;9:797072. https:\/\/doi.org\/10.3389\/fcell.2021.797072","journal-title":"Front Cell Dev Biol"},{"key":"942_CR59","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/schbul\/sbac050","volume":"48","author":"SM Silverstein","year":"2022","unstructured":"Silverstein SM, Choi JJ, Green KM, Bowles-Johnson KE, Ramchandran RS. Schizophrenia in translation: why the eye? Schizophr Bull. 2022;48:728\u201337.","journal-title":"Schizophr Bull"},{"key":"942_CR60","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.720167","volume":"13","author":"A Majeed","year":"2021","unstructured":"Majeed A, Marwick B, Yu H, Fadavi H, Tavakoli M. Ophthalmic biomarkers for Alzheimer\u2019s disease: a review. Front Aging Neurosci. 2021;13:720167.","journal-title":"Front Aging Neurosci"},{"key":"942_CR61","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1109\/RBME.2022.3161352","volume":"16","author":"G Harris","year":"2023","unstructured":"Harris G, Rickard JJS, Butt G, et al. Review: emerging eye-based diagnostic technologies for traumatic brain injury. IEEE Rev Biomed Eng. 2023;16:530\u201359.","journal-title":"IEEE Rev Biomed Eng"},{"key":"942_CR62","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1007\/s10439-023-03365-0","volume":"51","author":"A Suh","year":"2023","unstructured":"Suh A, Ong J, Kamran SA, et al. Retina oculomics in neurodegenerative disease. Ann Biomed Eng. 2023;51:2708\u201321.","journal-title":"Ann Biomed Eng"},{"key":"942_CR63","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4103\/ijo.IJO_999_19","volume":"68","author":"A Singh","year":"2020","unstructured":"Singh A, Verma S. Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer\u2019s disease. Indian J Ophthalmol. 2020;68:555.","journal-title":"Indian J Ophthalmol"},{"key":"942_CR64","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/eye.2015.158","volume":"29","author":"E Jones-Odeh","year":"2015","unstructured":"Jones-Odeh E, Hammond CJ. How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer\u2019s disease and multiple sclerosis? Eye (Lond). 2015;29:1270\u201384.","journal-title":"Eye (Lond)"},{"key":"942_CR65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fneur.2016.00055","volume":"7","author":"FZ Javaid","year":"2016","unstructured":"Javaid FZ, Brenton J, Guo L, Cordeiro MF. Visual and ocular manifestations of Alzheimer\u2019s disease and their use as biomarkers for diagnosis and progression. Front Neurol. 2016;7:55.","journal-title":"Front Neurol"},{"key":"942_CR66","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198608213150804","volume":"315","author":"DR Hinton","year":"1986","unstructured":"Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer\u2019s disease. N Engl J Med. 1986;315:485\u20137.","journal-title":"N Engl J Med"},{"key":"942_CR67","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/WCO.0000000000000645","volume":"32","author":"CY Cheung","year":"2019","unstructured":"Cheung CY, Chan VTT, Mok VC, Chen C, Wong TY. Potential retinal biomarkers for dementia: what is new? Curr Opin Neurol. 2019;32:82\u201391.","journal-title":"Curr Opin Neurol"},{"key":"942_CR68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.dadm.2015.03.001","volume":"1","author":"KL Thomson","year":"2015","unstructured":"Thomson KL, Yeo JM, Waddell B, Cameron JR, Pal S. A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography. Alzheimers Dement (Amst). 2015;1:136\u201343.","journal-title":"Alzheimers Dement (Amst)"},{"key":"942_CR69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134750","volume":"10","author":"G Coppola","year":"2015","unstructured":"Coppola G, Di Renzo A, Ziccardi L, et al. Optical coherence tomography in Alzheimer\u2019s disease: a meta-analysis. PLoS One. 2015;10:e0134750.","journal-title":"PLoS One"},{"key":"942_CR70","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1001\/jamaneurol.2018.1578","volume":"75","author":"F Ko","year":"2018","unstructured":"Ko F, Muthy ZA, Gallacher J, et al. Association of retinal nerve fiber layer thinning with current and future cognitive decline: a study using optical coherence tomography. JAMA Neurol. 2018;75:1198.","journal-title":"JAMA Neurol"},{"key":"942_CR71","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/jamaneurol.2018.1563","volume":"75","author":"U Mutlu","year":"2018","unstructured":"Mutlu U, Colijn JM, Ikram MA, et al. Association of retinal neurodegeneration on optical coherence tomography with dementia: a population-based study. JAMA Neurol. 2018;75:1256.","journal-title":"JAMA Neurol"},{"key":"942_CR72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archopht.1991.01080020045040","volume":"109","author":"CS Tsai","year":"1991","unstructured":"Tsai CS, Ritch R, Schwartz B, et al. Optic nerve head and nerve fiber layer in Alzheimer\u2019s disease. Arch Ophthalmol. 1991;109:199\u2013204.","journal-title":"Arch Ophthalmol"},{"key":"942_CR73","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clineuro.2015.02.016","volume":"132","author":"MP Bambo","year":"2015","unstructured":"Bambo MP, Garcia-Martin E, Gutierrez-Ruiz F, et al. Analysis of optic disk color changes in Alzheimer\u2019s disease: a potential new biomarker. Clin Neurol Neurosurg. 2015;132:68\u201373.","journal-title":"Clin Neurol Neurosurg"},{"key":"942_CR74","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/WAD.0000000000000176","volume":"31","author":"A Trebbastoni","year":"2017","unstructured":"Trebbastoni A, Marcelli M, Mallone F, et al. Attenuation of choroidal thickness in patients with Alzheimer disease: evidence from an Italian prospective study. Alzheimer Dis Assoc Disord. 2017;31:128\u201334.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"942_CR75","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.dadm.2015.01.004","volume":"1","author":"GT Feke","year":"2015","unstructured":"Feke GT, Hyman BT, Stern RA, Pasquale LR. Retinal blood flow in mild cognitive impairment and Alzheimer\u2019s disease. Alzheimers Dement (Amst). 2015;1:144\u201351.","journal-title":"Alzheimers Dement (Amst)"},{"key":"942_CR76","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, et al. Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 2011;54:S204\u201317.","journal-title":"Neuroimage"},{"key":"942_CR77","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93621","volume":"2","author":"Y Koronyo","year":"2017","unstructured":"Koronyo Y, Biggs D, Barron E, et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight. 2017;2:e93621.","journal-title":"JCI Insight"},{"key":"942_CR78","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/826503","volume":"2014","author":"T Tian","year":"2014","unstructured":"Tian T, Zhang B, Jia Y, Li Z. Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer\u2019s disease. Dis Markers. 2014;2014:826503.","journal-title":"Dis Markers"},{"key":"942_CR79","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(03)12981-9","volume":"361","author":"LE Goldstein","year":"2003","unstructured":"Goldstein LE, Muffat JA, Cherny RA, et al. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer\u2019s disease. Lancet. 2003;361:1258\u201365.","journal-title":"Lancet"},{"key":"942_CR80","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10384-004-0156-x","volume":"49","author":"S Yoneda","year":"2005","unstructured":"Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H. Vitreous fluid levels of beta-amyloid((1\u201342)) and tau in patients with retinal diseases. Jpn J Ophthalmol. 2005;49:106\u20138.","journal-title":"Jpn J Ophthalmol"},{"key":"942_CR81","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3233\/JAD-2010-100210","volume":"20","author":"A Prakasam","year":"2010","unstructured":"Prakasam A, Muthuswamy A, Ablonczy Z, et al. Differential accumulation of secreted AbetaPP metabolites in ocular fluids. J Alzheimers Dis. 2010;20:1243\u201353.","journal-title":"J Alzheimers Dis"},{"key":"942_CR82","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1111\/aos.12609","volume":"93","author":"S Jentsch","year":"2015","unstructured":"Jentsch S, Schweitzer D, Schmidtke K-U, et al. Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer\u2019s disease. Acta Ophthalmol. 2015;93:e241\u20137.","journal-title":"Acta Ophthalmol"},{"key":"942_CR83","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3233\/JAD-171145","volume":"62","author":"RN Martins","year":"2018","unstructured":"Martins RN, Villemagne V, Sohrabi HR, et al. Alzheimer\u2019s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies-gains from AIBL and DIAN cohort studies. J Alzheimers Dis. 2018;62:965\u201392.","journal-title":"J Alzheimers Dis"},{"key":"942_CR84","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000004500","volume":"89","author":"BJ Kim","year":"2017","unstructured":"Kim BJ, Irwin DJ, Song D, et al. Optical coherence tomography identifies outer retina thinning in frontotemporal degeneration. Neurology. 2017;89:1604\u201311.","journal-title":"Neurology"},{"key":"942_CR85","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fnins.2019.00298","volume":"13","author":"BJ Kim","year":"2019","unstructured":"Kim BJ, Grossman M, Song D, et al. Persistent and progressive outer retina thinning in frontotemporal degeneration. Front Neurosci. 2019;13:298.","journal-title":"Front Neurosci"},{"key":"942_CR86","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3233\/JAD-161078","volume":"56","author":"EL Granholm","year":"2017","unstructured":"Granholm EL, Panizzon MS, Elman JA, et al. Pupillary responses as a biomarker of early risk for Alzheimer\u2019s disease. J Alzheimers Dis. 2017;56:1419\u201328.","journal-title":"J Alzheimers Dis"},{"key":"942_CR87","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/02713683.2014.930154","volume":"40","author":"N \u00d6rnek","year":"2015","unstructured":"\u00d6rnek N, Da\u011f E, \u00d6rnek K. Corneal sensitivity and tear function in neurodegenerative diseases. Curr Eye Res. 2015;40:423\u20138.","journal-title":"Curr Eye Res"},{"key":"942_CR88","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.556137","volume":"14","author":"C Dehghani","year":"2020","unstructured":"Dehghani C, Frost S, Jayasena R, et al. Morphometric changes to corneal dendritic cells in individuals with mild cognitive impairment. Front Neurosci. 2020;14: 556137.","journal-title":"Front Neurosci"},{"key":"942_CR89","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/acn3.746","volume":"6","author":"G Ponirakis","year":"2019","unstructured":"Ponirakis G, Al Hamad H, Sankaranarayanan A, et al. Association of corneal nerve fiber measures with cognitive function in dementia. Ann Clin Transl Neurol. 2019;6:689\u201397.","journal-title":"Ann Clin Transl Neurol"},{"key":"942_CR90","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3233\/JAD-200678","volume":"77","author":"E Al-Janahi","year":"2020","unstructured":"Al-Janahi E, Ponirakis G, Al Hamad H, et al. Corneal nerve and brain imaging in mild cognitive impairment and dementia. J Alzheimers Dis. 2020;77:1533\u201343.","journal-title":"J Alzheimers Dis"},{"key":"942_CR91","first-page":"1744","volume":"60","author":"M Gijs","year":"2019","unstructured":"Gijs M, Nuijts RM, Ramakers I, Verhey F, Webers CAB. Differences in tear protein biomarkers between patients with Alzheimer\u2019s disease and controls. Invest Ophthalmol Vis Sci. 2019;60:1744\u20131744.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"942_CR92","doi-asserted-by":"crossref","first-page":"15437","DOI":"10.1038\/s41598-019-51837-y","volume":"9","author":"A Kenny","year":"2019","unstructured":"Kenny A, Jim\u00e9nez-Mateos EM, Zea-Sevilla MA, et al. Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer\u2019s disease. Sci Rep. 2019;9:15437.","journal-title":"Sci Rep"},{"key":"942_CR93","doi-asserted-by":"crossref","first-page":"8099","DOI":"10.1021\/acs.analchem.0c04980","volume":"93","author":"Y-R Wang","year":"2021","unstructured":"Wang Y-R, Chuang H-C, Tripathi A, et al. High-sensitivity and trace-amount specimen electrochemical sensors for exploring the levels of \u03b2-amyloid in human blood and tears. Anal Chem. 2021;93:8099\u2013106.","journal-title":"Anal Chem"},{"key":"942_CR94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158000","volume":"11","author":"G Kall\u00f3","year":"2016","unstructured":"Kall\u00f3 G, Emri M, Varga Z, et al. Changes in the chemical barrier composition of tears in Alzheimer\u2019s disease reveal potential tear diagnostic biomarkers. PLoS ONE. 2016;11: e0158000.","journal-title":"PLoS ONE"},{"key":"942_CR95","first-page":"4163239","volume":"2018","author":"J Huang","year":"2018","unstructured":"Huang J, Li Y, Xiao J, et al. Combination of multifocal electroretinogram and spectral-domain OCT can increase diagnostic efficacy of Parkinson\u2019s disease. Parkinsons Dis. 2018;2018:4163239.","journal-title":"Parkinsons Dis"},{"key":"942_CR96","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1111\/aos.12764","volume":"93","author":"B Stemplewitz","year":"2015","unstructured":"Stemplewitz B, Keser\u00fc M, Bittersohl D, et al. Scanning laser polarimetry and spectral domain optical coherence tomography for the detection of retinal changes in Parkinson\u2019s disease. Acta Ophthalmol. 2015;93:e672\u20137.","journal-title":"Acta Ophthalmol"},{"key":"942_CR97","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10072-018-3244-2","volume":"39","author":"M Unlu","year":"2018","unstructured":"Unlu M, Gulmez Sevim D, Gultekin M, Karaca C. Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson\u2019s disease. Neurol Sci. 2018;39:533\u201341.","journal-title":"Neurol Sci"},{"key":"942_CR98","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s10792-023-02653-x","volume":"43","author":"EE Christou","year":"2023","unstructured":"Christou EE, Konitsiotis S, Pamporis K, et al. Inner retinal layers\u2019 alterations of the microvasculature in early stages of Parkinson\u2019s disease: a cross sectional study. Int Ophthalmol. 2023;43:2533\u201343.","journal-title":"Int Ophthalmol"},{"key":"942_CR99","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/08820538.2021.1987482","volume":"37","author":"EE Christou","year":"2022","unstructured":"Christou EE, Asproudis I, Asproudis C, Giannakis A, Stefaniotou M, Konitsiotis S. Macular microcirculation characteristics in Parkinson\u2019s disease evaluated by OCT-angiography: a literature review. Semin Ophthalmol. 2022;37:399\u2013407.","journal-title":"Semin Ophthalmol"},{"key":"942_CR100","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1167\/iovs.17-23230","volume":"59","author":"WR Kwapong","year":"2018","unstructured":"Kwapong WR, Ye H, Peng C, et al. Retinal microvascular impairment in the early stages of Parkinson\u2019s disease. Invest Ophthalmol Vis Sci. 2018;59:4115\u201322.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"942_CR101","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neulet.2013.08.019","volume":"553","author":"SS \u00c7omo\u011flu","year":"2013","unstructured":"\u00c7omo\u011flu SS, G\u00fcven H, Acar M, \u00d6zt\u00fcrk G, Ko\u00e7er B. Tear levels of tumor necrosis factor-alpha in patients with Parkinson\u2019s disease. Neurosci Lett. 2013;553:63\u20137.","journal-title":"Neurosci Lett"},{"key":"942_CR102","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mds.26486","volume":"31","author":"C Andrade","year":"2016","unstructured":"Andrade C, Beato J, Monteiro A, et al. Spectral-domain optical coherence tomography as a potential biomarker in Huntington\u2019s disease. Mov Disord. 2016;31:377\u201383.","journal-title":"Mov Disord"},{"key":"942_CR103","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10072-020-04611-2","volume":"42","author":"LG Di Maio","year":"2021","unstructured":"Di Maio LG, Montorio D, Peluso S, et al. Optical coherence tomography angiography findings in Huntington\u2019s disease. Neurol Sci. 2021;42:995\u20131001.","journal-title":"Neurol Sci"},{"key":"942_CR104","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","volume":"9","author":"A Petzold","year":"2010","unstructured":"Petzold A, De Boer JF, Schippling S, et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2010;9:921\u201332.","journal-title":"Lancet Neurol"},{"key":"942_CR105","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41433-017-0010-2","volume":"32","author":"J Britze","year":"2018","unstructured":"Britze J, Frederiksen JL. Optical coherence tomography in multiple sclerosis. Eye. 2018;32:884\u20138.","journal-title":"Eye"},{"key":"942_CR106","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/acn3.51473","volume":"8","author":"F Paul","year":"2021","unstructured":"Paul F, Calabresi PA, Barkhof F, et al. Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study. Ann Clin Transl Neurol. 2021;8:2235\u201351.","journal-title":"Ann Clin Transl Neurol"},{"key":"942_CR107","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104416","volume":"133","author":"A Montol\u00edo","year":"2021","unstructured":"Montol\u00edo A, Mart\u00edn-Gallego A, Cego\u00f1ino J, et al. Machine learning in diagnosis and disability prediction of multiple sclerosis using optical coherence tomography. Comput Biol Med. 2021;133:104416.","journal-title":"Comput Biol Med"},{"key":"942_CR108","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/s22010167","volume":"22","author":"A L\u00f3pez-Dorado","year":"2021","unstructured":"L\u00f3pez-Dorado A, Ortiz M, Satue M, et al. Early diagnosis of multiple sclerosis using swept-source optical coherence tomography and convolutional neural networks trained with data augmentation. Sensors (Basel). 2021;22:167.","journal-title":"Sensors (Basel)"},{"key":"942_CR109","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.36.4.547","volume":"36","author":"PK Coyle","year":"1986","unstructured":"Coyle PK, Sibony PA. Tear analysis in multiple sclerosis. Neurology. 1986;36:547\u201350.","journal-title":"Neurology"},{"key":"942_CR110","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1212\/WNL.37.5.853","volume":"37","author":"PK Coyle","year":"1987","unstructured":"Coyle PK, Sibony P, Johnson C. Oligoclonal IgG in tears. Neurology. 1987;37:853\u20136.","journal-title":"Neurology"},{"key":"942_CR111","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-5728(93)90036-X","volume":"44","author":"G Martino","year":"1993","unstructured":"Martino G, Servalli C, Filippi M, et al. Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients. J Neuroimmunol. 1993;44:149\u201355.","journal-title":"J Neuroimmunol"},{"key":"942_CR112","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/PL00007833","volume":"248","author":"D Devos","year":"2001","unstructured":"Devos D, Forzy G, de Seze J, et al. Silver stained isoelectrophoresis of tears and cerebrospinal fluid in multiple sclerosis. J Neurol. 2001;248:672\u20135.","journal-title":"J Neurol"},{"key":"942_CR113","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1212\/WNL.40.8.1259","volume":"40","author":"M Mavra","year":"1990","unstructured":"Mavra M, Thompson EJ, Nikolic J, et al. The occurrence of oligoclonal IgG in tears from patients with MS and systemic immune disorders. Neurology. 1990;40:1259\u201362.","journal-title":"Neurology"},{"key":"942_CR114","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neurol.2014.11.007","volume":"171","author":"C Lebrun","year":"2015","unstructured":"Lebrun C, Forzy G, Collongues N, et al. Tear analysis as a tool to detect oligoclonal bands in radiologically isolated syndrome. Rev Neurol (Paris). 2015;171:390\u20133.","journal-title":"Rev Neurol (Paris)"},{"key":"942_CR115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/prca.201300053","volume":"8","author":"C Salvisberg","year":"2014","unstructured":"Salvisberg C, Tajouri N, Hainard A, Burkhard PR, Lalive PH, Turck N. Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis. Proteomics Clin Appl. 2014;8:185\u201394.","journal-title":"Proteomics Clin Appl"},{"key":"942_CR116","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/acn3.46","volume":"1","author":"M Ringelstein","year":"2014","unstructured":"Ringelstein M, Albrecht P, S\u00fcdmeyer M, et al. Subtle retinal pathology in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2014;1:290\u20137.","journal-title":"Ann Clin Transl Neurol"},{"key":"942_CR117","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00415-018-8787-x","volume":"265","author":"A Abdelhak","year":"2018","unstructured":"Abdelhak A, H\u00fcbers A, B\u00f6hm K, Ludolph AC, Kassubek J, Pinkhardt EH. In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis. J Neurol. 2018;265:949\u201353.","journal-title":"J Neurol"},{"key":"942_CR118","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/S2045796017000166","volume":"27","author":"J Westman","year":"2018","unstructured":"Westman J, Eriksson SV, Gissler M, et al. Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study. Epidemiol Psychiatr Sci. 2018;27:519\u201327.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"942_CR119","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.scog.2015.03.004","volume":"2","author":"SM Silverstein","year":"2015","unstructured":"Silverstein SM, Rosen R. Schizophrenia and the eye. Schizophr Res Cogn. 2015;2:46\u201355.","journal-title":"Schizophr Res Cogn"},{"key":"942_CR120","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbz106","author":"CT Kazakos","year":"2019","unstructured":"Kazakos CT, Karageorgiou V. Retinal changes in schizophrenia: a systematic review and meta-analysis based on individual participant data. Schizophr Bull. 2019. https:\/\/doi.org\/10.1093\/schbul\/sbz106.","journal-title":"Schizophr Bull"},{"key":"942_CR121","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/schbul\/sbx130","volume":"44","author":"NN Samani","year":"2018","unstructured":"Samani NN, Proudlock FA, Siram V, et al. Retinal layer abnormalities as biomarkers of schizophrenia. Schizophr Bull. 2018;44:876\u201385.","journal-title":"Schizophr Bull"},{"key":"942_CR122","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5152\/alphapsychiatry.2021.21207","volume":"23","author":"A Kurt","year":"2022","unstructured":"Kurt A, Ramazan Zor K, K\u00fc\u00e7\u00fck E, Y\u0131ld\u0131r\u0131m G, Erdal EE. An optical coherence tomography study that supports the neurovascular basis of schizophrenia disease. Alpha Psychiatry. 2022;23:12\u20137.","journal-title":"Alpha Psychiatry"},{"key":"942_CR123","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscychresns.2020.111061","volume":"299","author":"D Bannai","year":"2020","unstructured":"Bannai D, Lizano P, Kasetty M, et al. Retinal layer abnormalities and their association with clinical and brain measures in psychotic disorders: a preliminary study. Psychiatry Res Neuroimaging. 2020;299:111061.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"942_CR124","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2022.836851","volume":"4","author":"KM Green","year":"2022","unstructured":"Green KM, Choi JJ, Ramchandran RS, Silverstein SM. OCT and OCT angiography offer new insights and opportunities in schizophrenia research and treatment. Front Digit Health. 2022;4:836851.","journal-title":"Front Digit Health"},{"key":"942_CR125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5935\/0004-2749.20150046","volume":"78","author":"T Cumurcu","year":"2015","unstructured":"Cumurcu T, Keser S, Cumurcu BE, Gunduz A, Kartalci S. Refraction and eye anterior segment parameters in schizophrenic patients. Arq Bras Oftalmol. 2015;78:180\u20134.","journal-title":"Arq Bras Oftalmol"},{"key":"942_CR126","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1017\/S1461145705005377","volume":"8","author":"R Shiloh","year":"2005","unstructured":"Shiloh R, Munitz H, Portuguese S, et al. Corneal temperature in schizophrenia patients. Int J Neuropsychopharmacol. 2005;8:537.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Pt 3","key":"942_CR127","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.expneurol.2014.11.004","volume":"275","author":"L Xu","year":"2016","unstructured":"Xu L, Nguyen JV, Lehar M, et al. Repetitive mild traumatic brain injury with impact acceleration in the mouse: multifocal axonopathy, neuroinflammation, and neurodegeneration in the visual system. Exp Neurol. 2016;275(Pt 3):436\u201349.","journal-title":"Exp Neurol"},{"key":"942_CR128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/EB.S183042","volume":"10","author":"C Childs","year":"2018","unstructured":"Childs C, Barker LA, Gage AM, Loosemore M. Investigating possible retinal biomarkers of head trauma in Olympic boxers using optical coherence tomography. Eye Brain. 2018;10:101\u201310.","journal-title":"Eye Brain"},{"key":"942_CR129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/14737159.2018.1428089","volume":"18","author":"KK Wang","year":"2018","unstructured":"Wang KK, Yang Z, Zhu T, et al. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn. 2018;18:165\u201380.","journal-title":"Expert Rev Mol Diagn"},{"key":"942_CR130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/jcm11010197","volume":"11","author":"A Al\u00e9-Chilet","year":"2021","unstructured":"Al\u00e9-Chilet A, Bernal-Morales C, Barraso M, et al. Optical coherence tomography angiography in type\u00a01 diabetes mellitus\u2014report 2: diabetic kidney disease. J Clin Med. 2021;11:197.","journal-title":"J Clin Med"},{"key":"942_CR131","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/diagnostics11091537","volume":"11","author":"C Bernal-Morales","year":"2021","unstructured":"Bernal-Morales C, Al\u00e9-Chilet A, Mart\u00edn-Pinardel R, et al. Optical coherence tomography angiography in type\u00a01 diabetes mellitus. Report 4: glycated haemoglobin. Diagnostics. 2021;11:1537.","journal-title":"Diagnostics"},{"key":"942_CR132","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1755-3768.2009.01711.x","volume":"88","author":"L Yeung","year":"2010","unstructured":"Yeung L, Sun C-C, Ku W-C, et al. Associations between chronic glycosylated haemoglobin (HbA1c) level and macular volume in diabetes patients without macular oedema. Acta Ophthalmol. 2010;88:753\u20138.","journal-title":"Acta Ophthalmol"},{"key":"942_CR133","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s13167-022-00292-3","volume":"13","author":"BR Kim","year":"2022","unstructured":"Kim BR, Yoo TK, Kim HK, et al. Oculomics for sarcopenia prediction: a machine learning approach toward predictive, preventive, and personalized medicine. EPMA J. 2022;13:367\u201382.","journal-title":"EPMA J"},{"key":"942_CR134","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.clnu.2014.03.007","volume":"33","author":"G Biolo","year":"2014","unstructured":"Biolo G, Cederholm T, Muscaritoli M. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr. 2014;33:737\u201348.","journal-title":"Clin Nutr"},{"key":"942_CR135","doi-asserted-by":"crossref","first-page":"9432","DOI":"10.1038\/s41598-020-65794-4","volume":"10","author":"N Gerrits","year":"2020","unstructured":"Gerrits N, Elen B, Craenendonck TV, et al. Age and sex affect deep learning prediction of cardiometabolic risk factors from retinal images. Sci Rep. 2020;10:9432.","journal-title":"Sci Rep"},{"key":"942_CR136","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41551-021-00745-6","volume":"5","author":"K Zhang","year":"2021","unstructured":"Zhang K, Liu X, Xu J, et al. Deep-learning models for the detection and incidence prediction of chronic kidney disease and type\u00a02 diabetes from retinal fundus images. Nat Biomed Eng. 2021;5:533\u201345.","journal-title":"Nat Biomed Eng"},{"key":"942_CR137","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/glycob\/cwu108","volume":"25","author":"T Nguyen-Khuong","year":"2015","unstructured":"Nguyen-Khuong T, Everest-Dass AV, Kautto L, Zhao Z, Willcox MDP, Packer NH. Glycomic characterization of basal tears and changes with diabetes and diabetic retinopathy. Glycobiology. 2015;25:269\u201383.","journal-title":"Glycobiology"},{"key":"942_CR138","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clinbiochem.2011.10.006","volume":"45","author":"H-J Kim","year":"2012","unstructured":"Kim H-J, Kim P-K, Yoo H-S, Kim C-W. Comparison of tear proteins between healthy and early diabetic retinopathy patients. Clin Biochem. 2012;45:60\u20137.","journal-title":"Clin Biochem"},{"key":"942_CR139","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajo.2007.11.011","volume":"145","author":"KS Park","year":"2008","unstructured":"Park KS, Kim SS, Kim JC, et al. Serum and tear levels of nerve growth factor in diabetic retinopathy patients. Am J Ophthalmol. 2008;145:432\u20137.","journal-title":"Am J Ophthalmol"},{"key":"942_CR140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1155\/EDR.2003.271","volume":"4","author":"G Pittenger","year":"2003","unstructured":"Pittenger G, Vinik A. Nerve growth factor and diabetic neuropathy. Exp Diabesity Res. 2003;4:271\u201385.","journal-title":"Exp Diabesity Res"},{"key":"942_CR141","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100196","volume":"2","author":"A Pinhas","year":"2022","unstructured":"Pinhas A, Migacz JV, Zhou DB, et al. Insights into sickle cell disease through the retinal microvasculature. Ophthalmol Sci. 2022;2:100196.","journal-title":"Ophthalmol Sci"},{"key":"942_CR142","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13613-020-00768-3","volume":"10","author":"E Courtie","year":"2020","unstructured":"Courtie E, Veenith T, Logan A, Denniston AK, Blanch RJ. Retinal blood flow in critical illness and systemic disease: a review. Ann Intensive Care. 2020;10:152.","journal-title":"Ann Intensive Care"},{"key":"942_CR143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/6079631","volume":"2022","author":"A Pinhas","year":"2022","unstructured":"Pinhas A, Zhou DB, Otero-Marquez O, et al. Efficacy of CRISPR-based gene editing in a sickle cell disease patient as measured through the eye. Case Rep Hematol. 2022;2022:1\u20136.","journal-title":"Case Rep Hematol"},{"key":"942_CR144","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jamaophthalmol.2018.6035","volume":"137","author":"S Keel","year":"2019","unstructured":"Keel S, Wu J, Lee PY, Scheetz J, He M. Visualizing deep learning models for the detection of referable diabetic retinopathy and glaucoma. JAMA Ophthalmol. 2019;137:288.","journal-title":"JAMA Ophthalmol"},{"key":"942_CR145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ophtha.2021.03.003","volume":"128","author":"AY Lee","year":"2021","unstructured":"Lee AY, Campbell JP, Hwang TS, Lum F, Chew EY. Recommendations for standardization of images in ophthalmology. Ophthalmology. 2021;128:969\u201370.","journal-title":"Ophthalmology"},{"key":"942_CR146","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jamaophthalmol.2019.3537","volume":"137","author":"J Enoch","year":"2019","unstructured":"Enoch J, McDonald L, Jones L, Jones PR, Crabb DP. Evaluating whether sight is the most valued sense. JAMA Ophthalmol. 2019;137:1317\u201320.","journal-title":"JAMA Ophthalmol"},{"key":"942_CR147","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/ICU.0000000000000887","volume":"33","author":"AK Denniston","year":"2022","unstructured":"Denniston AK, Kale AU, Lee WH, Mollan SP, Keane PA. Building trust in real-world data: lessons from INSIGHT, the UK\u2019s health data research hub for eye health and oculomics. Curr Opin Ophthalmol. 2022;33:399\u2013406.","journal-title":"Curr Opin Ophthalmol"},{"key":"942_CR148","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41551-022-00867-5","volume":"6","author":"B Babenko","year":"2022","unstructured":"Babenko B, Mitani A, Traynis I, et al. Detection of signs of disease in external photographs of the eyes via deep learning. Nat Biomed Eng. 2022;6:1370\u201383.","journal-title":"Nat Biomed Eng"},{"key":"942_CR149","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.3390\/s23229130","volume":"23","author":"D Di Filippo","year":"2023","unstructured":"Di Filippo D, Sunstrum FN, Khan JU, Welsh AW. Non-invasive glucose sensing technologies and products: a comprehensive review for researchers and clinicians. Sensors (Basel). 2023;23:9130.","journal-title":"Sensors (Basel)"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-00942-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-024-00942-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-00942-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T08:31:58Z","timestamp":1716280318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-024-00942-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":150,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["942"],"URL":"https:\/\/doi.org\/10.1007\/s40123-024-00942-x","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Emily Patterson, Alistair Bounds, Richard Kadri-Langford, Robin Taylor and Dan Daly are employed by Occuity. Alistair Bounds and Richard Kadri-Langford are investors in Occuity. Robin Taylor and Dan Daly are investors in, co-founders and board members of, and hold patents with Occuity. Siegfried Wagner declares no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}